Edition:
United Kingdom

GenMark Diagnostics Inc (GNMK.OQ)

GNMK.OQ on NASDAQ Stock Exchange Global Market

6.32USD
24 Apr 2018
Change (% chg)

-- (--)
Prev Close
$6.32
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
122,501
52-wk High
$13.67
52-wk Low
$3.63

Chart for

About

GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers... (more)

Overall

Beta: 0.86
Market Cap(Mil.): $532.46
Shares Outstanding(Mil.): 54.67
Dividend: --
Yield (%): --

Financials

  GNMK.OQ Industry Sector
P/E (TTM): -- 148.40 32.74
EPS (TTM): -1.22 -- --
ROI: -71.43 9.37 14.38
ROE: -93.01 14.69 16.07

BRIEF-Casdin Capital Reports 7 Pct Stake In Genmark Diagnostics

* CASDIN CAPITAL REPORTS A 7 PERCENT STAKE IN GENMARK DIAGNOSTICS AS OF MARCH 20 - SEC FILING Source text: [https://bit.ly/2IYGIH9] Further company coverage:

27 Mar 2018

BRIEF-Genmark Diagnostics Q4 Loss Per Share $0.26

* GENMARK DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

27 Feb 2018

BRIEF-GenMark Diagnostics Sees Q4 2017 Revenue About $16 Mln

* GENMARK DIAGNOSTICS PROVIDES PRELIMINARY OPERATIONAL AND FINANCIAL RESULTS FOR 2017

09 Jan 2018

BRIEF-Genmark Diagnostics Entered Fifth Amendment To Loan And Security Agreement

* GENMARK DIAGNOSTICS INC - ON DEC 13 CO ENTERED FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT WITH SOLAR SENIOR CAPITAL - SEC FILING

14 Dec 2017

BRIEF-Genmark Diagnostics Q3 loss per share $0.28

* Q3 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S

02 Nov 2017

Earnings vs. Estimates